| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 12/28/2006 | CA2610326A1 Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kv1.5 potassium channel blockers and pharmaceutical preparations comprising them |
| 12/28/2006 | CA2608929A1 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase |
| 12/27/2006 | EP1736472A1 2-aminopyridine derivative |
| 12/27/2006 | EP1736471A1 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines |
| 12/27/2006 | EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators |
| 12/27/2006 | EP1736468A2 Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation |
| 12/27/2006 | EP1736467A1 Novel sulfonamide derivative |
| 12/27/2006 | EP1736466A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 12/27/2006 | EP1736465A1 Aniline derivatives |
| 12/27/2006 | EP1735319A1 Inhibitors of histone deacetylase |
| 12/27/2006 | EP1735307A1 Inhibitors of iap |
| 12/27/2006 | EP1735302A1 4-amino-piperidine derivatives as monoamine uptake inhibitors |
| 12/27/2006 | EP1735299A1 Tertrahydrobenzazepines as histamine h3 receptor ligands |
| 12/27/2006 | EP1735298A1 Piperidine derivates for the treatment of chemokines mediared disease |
| 12/27/2006 | EP1735287A1 Therapeutic agents |
| 12/27/2006 | EP1735286A1 Tetrahydro-indazole cannabinoid modulators |
| 12/27/2006 | EP1735284A1 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides |
| 12/27/2006 | EP1735282A1 Pyrazole compounds and uses related thereto |
| 12/27/2006 | EP1735280A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
| 12/27/2006 | EP1735278A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 12/27/2006 | EP1734966A2 Piperizinylpiperidine derivatives as chemokine receptor antagonists |
| 12/27/2006 | EP1734964A1 17 beta-acetamide-4-azasteroids as androgen receptor modulators |
| 12/27/2006 | EP1734951A2 Diphenyl-indol-2-on compounds and their use in the treatment of cancer |
| 12/27/2006 | EP1660476B1 Haloalkyl- and piperidine-substituted benzimidazole-derivatives |
| 12/27/2006 | EP1608317A4 Dipeptidyl peptidase inhibitors |
| 12/27/2006 | EP1597260B1 Triazole compounds useful in therapy |
| 12/27/2006 | EP1558255B1 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease |
| 12/27/2006 | EP1554259B1 Novel bicyclic inhibitors of hormone sensitive lipase |
| 12/27/2006 | EP1534282B1 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 12/27/2006 | EP1471786B1 Microbiocidal n-phenyl-n- 4-(4-pyridyl)-2-pyrimidin-2-yl|-amine derivatives |
| 12/27/2006 | EP1436267B1 Lactam derivatives as antagonists for human 11cby receptors |
| 12/27/2006 | EP1406876B1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 12/27/2006 | EP1379515B1 Lipid lowering biphenylcarboxamides |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | CN1886421A Hemiasterlin derivatives and uses thereof |
| 12/27/2006 | CN1886402A pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists |
| 12/27/2006 | CN1886399A 喹唑啉衍生物 Quinazoline derivatives |
| 12/27/2006 | CN1886398A Thioether-substituted benzamides as inhibitors of factor Xa |
| 12/27/2006 | CN1886397A 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3) |
| 12/27/2006 | CN1886391A Tetronic and tetramic acids as inhibitors of beta-secrease |
| 12/27/2006 | CN1886388A Developments in biologically active methylene blue derivatives(2) |
| 12/27/2006 | CN1886386A Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 12/27/2006 | CN1886384A Quinazolinone compounds as anticancer agents |
| 12/27/2006 | CN1886381A Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 12/27/2006 | CN1886380A Benzoimidazole compounds |
| 12/27/2006 | CN1886378A 1,4-disubstituted isoquinilone derivatives as RAF-kinase inhibitors useful for the treatment of proliferative diseases |
| 12/27/2006 | CN1886376A Pyridine compounds as inhibitors of dipeptidyl peptidase iv |
| 12/27/2006 | CN1291984C 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry |
| 12/27/2006 | CN1291976C Antiretroviral pyridine and quinoline derivatives |
| 12/27/2006 | CN1291975C New mandelic acid derivatives and their use as thrombase inhibitors |
| 12/26/2006 | US7153968 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease, eosinophilic granuloma, psoriasis and other benign or malignant proliferative skin diseases, endotoxic shock, laminitis in horses, colic in horses, septic shock, ulcerative colitis, Crohn's disease, reperfusion injury |
| 12/26/2006 | US7153964 Pyrimidine compounds |
| 12/26/2006 | US7153963 Phenylalanine derivatives |
| 12/26/2006 | US7153960 Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 12/26/2006 | US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 12/26/2006 | US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics |
| 12/26/2006 | US7153883 Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
| 12/26/2006 | US7153881 Compounds acting as melanocortin receptor ligands |
| 12/26/2006 | US7153875 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
| 12/26/2006 | US7153874 For therapy and prophylaxis of of disorders mediated in full or in part by metabotropic glutamate receptor 5, including, e.g. acute, traumatic and chronic degenerative processes of the nervous system, such as Alzheimer's disease, senile dementia, Parkinson's disease, Huntington's chorea |
| 12/26/2006 | US7153872 Cancer and fibrotic diseases |
| 12/26/2006 | US7153871 Antiinflammatory agents; cognition activators; asthma therapy; antiarthritic agents; side effect reduction |
| 12/26/2006 | US7153870 Nicotinamide derivatives useful as PDE4 inhibitors |
| 12/26/2006 | US7153868 N-(3-(4-substituted-1-piperidinyl)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists |
| 12/26/2006 | US7153867 Use of nitrogen substituted thalidomide analogs for the treatment of macular degenerator |
| 12/26/2006 | US7153863 Therapeutic compounds based on pyrazolopyridline derivatives |
| 12/26/2006 | US7153862 αv integrin receptor antagonists |
| 12/26/2006 | US7153861 5,6 -Trimethylenepyrimidin-4-one compounds |
| 12/26/2006 | US7153860 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 12/26/2006 | US7153858 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches |
| 12/26/2006 | US7153857 antiinflammatory agents; antiarthritic agents; anticancer agents |
| 12/26/2006 | US7153855 Pyrazolopyridinyl pyrimidine therapeutic compounds |
| 12/26/2006 | US7153849 5HT1A antagonist; obsessive-compulsive disorder, panic attacks, generalized anxiety disorder, and social anxiety disorder |
| 12/21/2006 | WO2006135828A2 Trisubstituted amines as phosphodiesterase 4 inhibitors |
| 12/21/2006 | WO2006135826A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/21/2006 | WO2006135721A1 Alkylquinoline and alkylquinazoline kinase modulators |
| 12/21/2006 | WO2006135719A1 Aminopyrimidines as kinase modulators |
| 12/21/2006 | WO2006135646A1 Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators and related methods of synthesis |
| 12/21/2006 | WO2006135644A1 Aminopyrimidines as kinase modulators |
| 12/21/2006 | WO2006135641A2 PROCESS FOR THE SYNTHESIS OF 5- (METHYL-lH-IMIDAZOL-l-YL) -3- (TRI FLUOROME TH YL) -BENZENEAMINE |
| 12/21/2006 | WO2006135323A1 Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives |
| 12/21/2006 | WO2006135312A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives |
| 12/21/2006 | WO2006134989A1 Nitrogenated heterocyclic compound |
| 12/21/2006 | WO2006134877A1 Injection |
| 12/21/2006 | WO2006134608A1 Gemifloxacin process and polymorphs |
| 12/21/2006 | WO2006134605A1 Amorphous esomeprazole hydrate |
| 12/21/2006 | WO2006134481A1 Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1 |
| 12/21/2006 | WO2006134468A1 Substituted arylpyrazoles for use against parasitites |
| 12/21/2006 | WO2006134466A1 Substituted arylpyrazoles as parasiticidal agents |
| 12/21/2006 | WO2006134459A1 Substituted arylpyrazoles |
| 12/21/2006 | WO2006134378A1 Compounds for the treatment of multi-drug resistant bacterial infections |
| 12/21/2006 | WO2006134318A1 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders |
| 12/21/2006 | WO2006133946A1 Azab i cyclo [3 . 1 . 0] hexane derivatives as dopamin d3 receptor modulators |
| 12/21/2006 | WO2006133926A1 Pyrazole derivates as cannabinoid receptor modulators |
| 12/21/2006 | WO2006133904A2 Methods and intermediates for the preparation of optionally radio-labeled imatinib |
| 12/21/2006 | WO2006133805A1 Tetrahydroquinoline derivatives |
| 12/21/2006 | WO2006133634A1 Tetrahydroindole derivatives and tetrahydroindazole derivatives, and use thereof |
| 12/21/2006 | WO2006133498A1 Acid addition salts of n-ethyi-n'-[2-methoxy-4-(5-methyi-4-{[(1s)-1-pyridin-3-ylbutyi]amino}pyrimidin- 2-yl)phenyl]urea and uses thereof |
| 12/21/2006 | WO2006117802A3 New process for synthesis of proton pump inhibitors |
| 12/21/2006 | WO2006092599A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |